Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miroslav Brozman

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Cardiology|June 4, 2018
Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trialDaša Viszlayová, Miroslav Brozman, Kateřina Langová, et al.
Stroke|April 16, 2011
Is the maximum dose of 90 mg alteplase sufficient for patients with ischemic stroke weighing >100 kg?Jennifer Diedler, Niaz Ahmed, Jörg Glahn, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 14, 2018
Interleukin 6 and complement serum level study in Parkinson's diseaseBranislav Veselý, Michal Dufek, Vojtech Thon, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 30, 2016
Plasmin (Human) Administration in Acute Middle Cerebral Artery Ischemic Stroke: Phase 1/2a, Open-Label, Dose-Escalation, Safety StudyPeter J Mitchell, Bernard Yan, Miroslav Brozman, et al.
Stroke|April 5, 2019
Safety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke OnsetCharith Cooray, Michael Mazya, Robert Mikulik, et al.
Bratislavske Lekarske Listy|August 28, 2023
Cognitive changes associated with cerebral emboli during coronary interventionDasa Viszlayova, David Skoloudik, Miroslav Brozman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 1, 2014
Hyperdense cerebral artery computed tomography sign is associated with stroke severity rather than stroke subtypeJana Novotná, Pavla Kadlecová, Anna Czlonkowska, et al.
BMC Cardiovascular Disorders|December 4, 2015
Detection of occult paroxysmal atrial fibrilation by implantable long-term electrocardiographic monitoring in cryptogenic stroke and transient ischemic attack population: a study protocol for prospective matched cohort studyAndrea Petrovičová, Egon Kurča, Miroslav Brozman, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 19, 2017
Novel missense variant of CACNA1A gene in a Slovak family with episodic ataxia type 2Andrea Petrovicova, Miroslav Brozman, Egon Kurca, et al.
Stroke|March 20, 2012
Factors influencing in-hospital delay in treatment with intravenous thrombolysisRobert Mikulík, Pavla Kadlecová, Anna Czlonkowska, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Cardiology|June 4, 2018
Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trialDaša Viszlayová, Miroslav Brozman, Kateřina Langová, et al.
Stroke|April 16, 2011
Is the maximum dose of 90 mg alteplase sufficient for patients with ischemic stroke weighing >100 kg?Jennifer Diedler, Niaz Ahmed, Jörg Glahn, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 14, 2018
Interleukin 6 and complement serum level study in Parkinson's diseaseBranislav Veselý, Michal Dufek, Vojtech Thon, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 30, 2016
Plasmin (Human) Administration in Acute Middle Cerebral Artery Ischemic Stroke: Phase 1/2a, Open-Label, Dose-Escalation, Safety StudyPeter J Mitchell, Bernard Yan, Miroslav Brozman, et al.
Stroke|April 5, 2019
Safety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke OnsetCharith Cooray, Michael Mazya, Robert Mikulik, et al.
Bratislavske Lekarske Listy|August 28, 2023
Cognitive changes associated with cerebral emboli during coronary interventionDasa Viszlayova, David Skoloudik, Miroslav Brozman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 1, 2014
Hyperdense cerebral artery computed tomography sign is associated with stroke severity rather than stroke subtypeJana Novotná, Pavla Kadlecová, Anna Czlonkowska, et al.
BMC Cardiovascular Disorders|December 4, 2015
Detection of occult paroxysmal atrial fibrilation by implantable long-term electrocardiographic monitoring in cryptogenic stroke and transient ischemic attack population: a study protocol for prospective matched cohort studyAndrea Petrovičová, Egon Kurča, Miroslav Brozman, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 19, 2017
Novel missense variant of CACNA1A gene in a Slovak family with episodic ataxia type 2Andrea Petrovicova, Miroslav Brozman, Egon Kurca, et al.
Stroke|March 20, 2012
Factors influencing in-hospital delay in treatment with intravenous thrombolysisRobert Mikulík, Pavla Kadlecová, Anna Czlonkowska, et al.
Pageof 2